Advanced search
Publication Cover
International Journal of the Economics of Business Volume 27, 2020 - Issue 1
Submit an article Journal homepage
1,112
Views
9
CrossRef citations to date
0
Altmetric
Articles

Four Facts Concerning Competition in US Generic Prescription Drug Markets

Rena M. ContiDepartment of Markets, Public Policy and Law, Questrom School of Business, Boston University, Boston, MA, USA; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-4190-1839
ORCID Icon &
Ernst R. BerndtApplied Economics, MIT Sloan School of Management, Cambridge, MA, USAORCID Iconhttp://orcid.org/0000-0002-6388-0768
ORCID Icon
Pages 27-48 | Published online: 05 Sep 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sarfaraz K Niazi. (2023) Biosimilars Adoption: Recognizing and Removing the RoadBlocks. ClinicoEconomics and Outcomes Research 15, pages 281-294.
Read now

Articles from other publishers (8)

Yixin (Iris) Wang, Jun Li & Ravi Anupindi. (2023) Manufacturing and Regulatory Barriers to Generic Drug Competition: A Structural Model Approach. Management Science 69:3, pages 1449-1467.
Crossref
Daniel J. Hemel & Lisa Larrimore Ouellette. (2023) The Generic Drug Trilemma. Entrepreneurship and Innovation Policy and the Economy 2, pages 41-77.
Crossref
Jun Li & Di (Andrew) Wu. (2022) The Price Effect of Drug Price Ceilings: Intended and Unintended Consequences. Management Science 68:8, pages 5758-5777.
Crossref
David Miller, Benedic Ippolito, Inmaculada Hernandez & Benjamin Davies. (2021) The Costs of Delayed Generic Drug Entry: Evidence from a Controversial Prostate Cancer Drug Patent. Journal of General Internal Medicine 37:3, pages 668-670.
Crossref
Daniel J. Hemel & Lisa Larrimore Ouellette. (2022) The Generic Drug Trilemma. SSRN Electronic Journal.
Crossref
Lucy Xiaolu Wang & Nahim Zahur. (2021) Procurement Institutions and Essential Drug Supply in Low and Middle-Income Countries. SSRN Electronic Journal.
Crossref
Jun Li & Di Wu. (2018) Intended and Unintended Consequences of Drug Price Regulations. SSRN Electronic Journal.
Crossref
Yixin (Iris) Wang, Jun Li & Ravi Anupindi. (2018) Manufacturing and Regulatory Barriers to Generic Drug Competition: A Structural Model Approach. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.